Scientific publications

Our scientific publications bring you facts and figures about healthcare in Switzerland. We use anonymised insurance data to examine the links between therapy results and the resources deployed, allowing us to draw conclusions about their effectiveness and efficiency.

Note: the publications are presented in their original language and are only available in that language.

Selected Tab: {"active":true,"title":"2026"}

Use of antidepressants before, during, and after pregnancy between 2015 and 2021 in Switzerland: a retrospective analysis of Swiss health care claims data

Long-Term Antidepressant Use and Dementia Risk: A Propensity Score-Matched Study of Swiss Older Adults, with an Anticholinergic-Specific Analysis

Population-Based Assessment of Phenoconversion Potential in Switzerland: A Claims Data Study of Key Drug-Metabolizing Enzymes and Transporters

Potentially inappropriate medication: prevalence, risk of hospitalisation and associated healthcare costs in the general older population of Switzerland

The risk of acute thromboembolic cardiovascular events in association with use of chondroitin sulphate: A comparative, propensity score-matched cohort study using Swiss healthcare claims data

Medication adherence to secondary prevention after ischemic cerebrovascular disease: a real-world outcomes analysis

Prevalence and patterns of anti-angiogenic treatment discontinuation in neovascular age-related macular degeneration - insights from health claims data

Post-Fracture Care and Predictors of Anti-Osteoporotic Treatment in Switzerland: A Nationwide Health Claims Analysis

Do you have questions?

We're here to help.